Literature DB >> 12349902

Remodeling of the left atrium in pacing-induced atrial cardiomyopathy.

Brian D Hoit1, Yasuchika Takeishi, Michael J Cox, Marorie Gabel, Darryl Kirkpatrick, Richard A Walsh, Suresh C Tyagi.   

Abstract

Rapid atrial pacing produces atrial systolic and diastolic failure characterized by absent atrial booster pump function, increased atrial chamber stiffness, enhanced atrial conduit function, and atrial enlargement. However, the processes underlying these abnormalities are poorly understood. Therefore, we examined left atrial myocardium from dogs with rapid pacing-induced atrial failure (400 bpm for 6 weeks) and from control dogs. Western blotting was used to determine the levels of proteins involved in calcium homeostasis (SERCA 2A, phospholamban, Na+-Ca2+ exchanger). Matrix metalloproteinase (MMP) activity was measured using gelatin and casein zymography, and levels of tissue inhibitor of metalloproteinase-4 (TIMP-4) and the TIMP-4 complexed with MMPs were measured with Western blot analysis. There were no differences in SERCA 2A or Na+-Ca2+ exchanger protein levels, but phospholamban level was significantly decreased in atrial samples from rapidly paced dogs (51.2 +/- 7.8 vs. 77.0 +/- 10.0, p < 0.01). The activity of MMP-9 was selectively and significantly increased by approximately 50%, and the level of complexed TIMP-4 protein was significantly decreased by approximately 50% in samples from dogs with atrial failure. Thus, rapid pacing-induced atrial failure is associated with differential changes in MMP activity, an unchanged number of calcium pumps, and compensatory changes in the level of phospholamban.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12349902     DOI: 10.1023/a:1019988024077

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.

Authors:  C V Thomas; M L Coker; J L Zellner; J R Handy; A J Crumbley; F G Spinale
Journal:  Circulation       Date:  1998-05-05       Impact factor: 29.690

Review 2.  Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation.

Authors:  S Nattel
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

Review 3.  Perspectives and controversies in atrial fibrillation.

Authors:  E N Prystowsky
Journal:  Am J Cardiol       Date:  1998-08-20       Impact factor: 2.778

4.  Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

Authors:  F G Spinale; M L Coker; C V Thomas; J D Walker; R Mukherjee; L Hebbar
Journal:  Circ Res       Date:  1998-03-09       Impact factor: 17.367

5.  beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction.

Authors:  H Senzaki; N Paolocci; Y A Gluzband; M L Lindsey; J S Janicki; M T Crow; D A Kass
Journal:  Circ Res       Date:  2000-04-14       Impact factor: 17.367

6.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.

Authors:  A J Sanfilippo; V M Abascal; M Sheehan; L B Oertel; P Harrigan; R A Hughes; A E Weyman
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

7.  Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure.

Authors:  Y Takeishi; A Bhagwat; N A Ball; D L Kirkpatrick; M Periasamy; R A Walsh
Journal:  Am J Physiol       Date:  1999-01

8.  Left atrial systolic and diastolic function accompanying chronic rapid pacing-induced atrial failure.

Authors:  B D Hoit; Y Shao; M Gabel
Journal:  Am J Physiol       Date:  1998-07

9.  Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.

Authors:  Y Y Li; A M Feldman; Y Sun; C F McTiernan
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

Review 10.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

View more
  14 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 2.  Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.

Authors:  Dorothea Rosenberger; Karni S Moshal; Ganesh K Kartha; Neetu Tyagi; Utpal Sen; David Lominadze; Claudio Maldonado; Andrew M Roberts; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

3.  Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.

Authors:  Srikanth Givvimani; Natia Qipshidze; Neetu Tyagi; Paras K Mishra; Utpal Sen; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-05-29

4.  Electrical stimulation of cardiomyocytes activates mitochondrial matrix metalloproteinase causing electrical remodeling.

Authors:  Thomas P Vacek; Naira Metreveli; Neetu Tyagi; Jonathan C Vacek; Sebastian Pagni; Suresh C Tyagi
Journal:  Biochem Biophys Res Commun       Date:  2010-12-16       Impact factor: 3.575

5.  [Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications].

Authors:  A Goette; U Lendeckel; H U Klein
Journal:  Z Kardiol       Date:  2004-11

6.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

7.  Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.

Authors:  Karni S Moshal; Srinivas M Tipparaju; Thomas P Vacek; Munish Kumar; Mahavir Singh; Iluiana E Frank; Phani K Patibandla; Neetu Tyagi; Jayesh Rai; Naira Metreveli; Walter E Rodriguez; Michael T Tseng; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.

Authors:  Karni S Moshal; Munish Kumar; Neetu Tyagi; Paras K Mishra; Naira Metreveli; Walter E Rodriguez; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

9.  Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism.

Authors:  Pankaj Chaturvedi; Anuradha Kalani; Srikanth Givvimani; Pradip Kumar Kamat; Anastasia Familtseva; Suresh C Tyagi
Journal:  Physiol Genomics       Date:  2014-02-04       Impact factor: 3.107

Review 10.  Cardiac dys-synchronization and arrhythmia in hyperhomocysteinemia.

Authors:  Karni S Moshal; Clacy K Camel; Ganesh K Kartha; Mesia M Steed; Neetu Tyagi; Utpal Sen; Y James Kang; David Lominadze; Claudio Maldonado; Suresh C Tyagi
Journal:  Curr Neurovasc Res       Date:  2007-11       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.